PAR
Click for more information
0.00% 27.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4101

  1. TanamiRod
    555 Posts.
    lightbulb Created with Sketch. 229
    clock Created with Sketch.
    24/05/24
    06:29
    Post #: 73985114
    Nice fund jcurve... So our friends at Bene are not just relying on PAR to assist in their potential growth, via pain from OA. Smart cookies.

    Interesting dosing regiment at 10mg/kg, just doesn't state how often.. It looks to be in a similar ballpark as Elmiron, which we know was BAD
    PAR Price at posting: 24.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $96.19M
Open High Low Value Volume
27.5¢ 28.5¢ 27.5¢ $50.60K 182.8K

Buyers (Bids)

No. Vol. Price($)
1 1818 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 27600 2
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.